Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 17:9:905394.
doi: 10.3389/fsurg.2022.905394. eCollection 2022.

Efficacy and Safety of Prostatic Artery Embolization in the Treatment of High Risk Benign Prostatic Hyperplasia and its Influence on Postoperative Life Quality of Patients

Kun Wang  1 , Ming Chen  2 , Yiqing Liu  1 , Weiren Xiao  1 , Yonghong Qian  1 , Xu Liu  3
Affiliations

Efficacy and Safety of Prostatic Artery Embolization in the Treatment of High Risk Benign Prostatic Hyperplasia and its Influence on Postoperative Life Quality of Patients

Kun Wang et al. Front Surg. .

Abstract

Objective: To evaluate the efficacy, safety and postoperative quality of life of high risk benign prostatic hyperplasia (BPH) patients treated with prostatic artery embolization.

Methods: 34 patients with high-risk BPH were selectedfrom January 2020 to June 2021 in our hospital. All patients were treated with prostatic artery embolization. The changes of international prostate symptom score (IPSS), prostate volume (PV), remaining urine (RU), maximum urine flow rate (Qmax), quality of life scale -74(GQOLI-74), time to sleep without disturbance (HUS) judgment, self-rating anxiety scale (SAS) score and self-rating depression scale (SDS) were compared before operation, 1 month and 6 months after operation.

Results: Prostatic artery embolization was successful in all 34 patients, including unilateral embolization in 15 patients and bilateral embolization in 19 patients. No severe complications occurred in the postoperative patients. The IPSS, PV and RU levels of the patient one month and six months after surgery were lower than those before surgery, while the Qmax level was higher than that before surgery. Besides, the IPSS, PV and RU levels six months after surgery were significantly lower than those one month after surgery, and the Qmax level was significantly higher than that one month after surgery (p < 0.05). The GQOLI-74 score six months after surgery was significantly higher than that before surgery (p < 0.05). The HUS of the patient six months after surgery was significantly increased, and the SAS and SDS scores were significantly decreased as compared with those before surgery (p < 0.05).

Conclusion: For high-risk patients with BPH, prostate embolization is an effective and safe method, which can significantly improve the quality of life of patients after surgery and has good application prospects.

Keywords: benign prostatic hyperplasia; high risk; prostatic artery; prostatic artery embolization; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Changes in IPSS of patients before and after surgery.
Figure 2
Figure 2
Changes in PV of patients before and after surgery.
Figure 3
Figure 3
Changes in Qmax of patients before and after surgery.
Figure 4
Figure 4
Changes in RU of patients before and after surgery.
Figure 5
Figure 5
Changes in psychological function scores of patients before and after surgery.
Figure 6
Figure 6
Changes in social function scores of patients before and after surgery.
Figure 7
Figure 7
Changes in material life scores of patients before and after surgery.
Figure 8
Figure 8
Changes in body function scores of patients before and after surgery. Note: compared with before surgery, *p < 0.05. Note: compared with before operation, *p < 0.05; compared with one month after surgery, #p < 0.05.
Figure 9
Figure 9
Changes of HUS in patients before and after surgery.
Figure 10
Figure 10
Changes of SAS and SDS scores in patients before and after surgery. Note: compared with before surgery, *p < 0.05.
See this image and copyright information in PMC

References

    1. Mokos I, El Saleh A, Kuliš T, Topalović Grković M, Bačak Kocman I, Kaštelan Ž. Surgical treatment of high-risk prostatic carcinoma and oligometastatic disease. Acta Clin Croat. (2019) 58:21–3. 10.20471/acc.2019.58.s2.04 - DOI - PMC - PubMed
    1. Meng Q, Li J, Li M, Qiu R. Evaluation of efficacy and safety of improved transurethral plasma kinetic enucleation of the prostate in high-risk patients with benign prosta tic hyperplasia and coronary artery disease. J Int Med Res. (2021) 49:3000605211060890. 10.1177/03000605211060890 - DOI - PMC - PubMed
    1. Zi H, Wang XJ, Zhao MJ, Huang Q, Wang XH, Zeng XT. Fasting blood glucose level and hypertension risk in aging benign prostatic hyperplasia patients. Aging (Albany NY). (2019) 11:4438–45. 10.18632/aging.102061 - DOI - PMC - PubMed
    1. Vartak KP, Raghuvanshi K. Outcome of thulium laser enucleation of prostate surgery in high-risk patients with benign prostatic hyperplasia. Urol Ann. (2019) 11:358–62. 10.4103/UA.UA_175_18 - DOI - PMC - PubMed
    1. Zhang ZY, Zhao MJ, Hong BA, Ma LL, Jin YH, Zeng XT, et al. [Transurethral bipolar plasmakinetic prostatectomy for benign prostatic hyperplasia in high-risk and senior patients in China: a systematic re view and meta-analysis]. Zhonghua Yi Xue Za Zhi. (2019) 99:778–82. 10.3760/cma.j.issn.0376-2491.2019.10.015 - DOI - PubMed

LinkOut - more resources